The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth
Abstract
BACKGROUND: Despite the widespread use of antenatal corticosteroids to prevent respiratory distress syndrome in preterm infants, there is currently no consensus as to the type of corticosteroid to use; nor the dose, frequency, timing of use or the route of administration. OBJECTIVES: To assess the effects of different corticosteroid regimens for women at risk of preterm birth. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (13 February 2013). SELECTION CRITERIA: All identified published and unpublished randomised controlled trials or quasi-randomised control trials comparing any two corticosteroids (dexamethasone or betamethasone or any other corticosteroid that can cross the placenta), comparing different dose regimens (including frequency and timing of administration) in women at risk of preterm birth were included. We planned to exclude cross-over trials and cluster-randomised trials. We included studies published as abstracts only along with studies published as full-text manuscripts DATA COLLECTION AND ANALYSIS: Two review authors independently assessed study eligibility, extracted data and assessed the risk of bias of included studies. Data were checked for accuracy. MAIN RESULTS: For this update, 12 trials (1557 women and 1661 infants) were included. Dexamethasone was associated with a reduced risk of intraventricular haemorrhage (IVH) compared with betamethasone (risk ratio (RR) 0.44, 95% confidence interval (CI) 0.21 to 0.92; four trials, 549 infants). No statistically significant differences were seen for other primary outcomes: respiratory distress syndrome (RDS) (RR 1.06, 95% CI 0.88 to 1.27; five trials, 753 infants) and perinatal death (neonatal death RR 1.41, 95% CI 0.54 to 3.67; four trials, 596 infants). Similarly, very few differences were seen for secondary outcomes such as rate of admission to the neonatal intensive care unit (NICU) although in one trial, those infants exposed to dexamethasone, compared with betamethasone, had a significantly shorter length of NICU admission (mean difference (MD) -0.91 days, 95% CI -1.77 to -0.05; 70 infants). Results for biophysical parameters were inconsistent, but mostly no clinically important differences were seen.Compared with intramuscular dexamethasone, oral dexamethasone significantly increased the incidence of neonatal sepsis (RR 8.48, 95% CI 1.11 to 64.93) in one trial of 183 infants. No statistically significant differences were seen for other outcomes reported.Apart from a reduced maternal postpartum length of stay for women who received betamethasone at 12-hourly intervals compared to 24-hourly intervals in one trial (MD -0.73 days, 95% CI -1.28 to -0.18; 215 women), no differences in maternal or neonatal outcomes were seen between the different betamethasone dosing intervals assessed. Similarly, no significant differences in outcomes were seen when betamethasone acetate and phosphate was compared with betamethasone phosphate in one trial. AUTHORS' CONCLUSIONS: It remains unclear whether one corticosteroid (or one particular regimen) has advantages over another.Dexamethasone may have some benefits compared with betamethasone such as less IVH, and a shorter length of stay in the NICU. The intramuscular route may have advantages over the oral route for dexamethasone, as identified in one small trial. Apart from the suggestion that 12-hour dosing may be as effective as 24-hour dosing of betamethasone based on one small trial, few other conclusions about optimal antenatal corticosteroid regimens were able to be made. No long-term results were available except for a small subgroup of 18 month old children in one trial. Trials comparing the commonly used corticosteroids are most urgently needed, as are trials of dosages and other variations in treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801
An overview of mortality and sequelae of preterm birth from infancy to adulthood
Saigal, S., & Doyle, L. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60136-1 · Cited by 2,818
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub3 · Cited by 2,806
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Born too soon : the Global action report on preterm birth
Howson, C. P., Kinney, M., & Lawn, J. E. (2012) · Cited by 1,928
Basic and Clinical Pharmacology
Katzung, B. G. (1982) · Andalas University Repository (Andalas University) · Cited by 1,914
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., & Dalziel, S. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub2 · Cited by 1,578
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
PREMATURE DELIVERY OF FOETAL LAMBS INFUSED WITH GLUCOCORTICOIDS
LIGGINS, G. C. (1969) · Journal of Endocrinology · doi:10.1677/joe.0.0450515 · Cited by 817
Scientific basis and therapeutic regimens for use of antenatal glucocorticoids
Ballard, P. L., & Ballard, R. A. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90210-4 · Cited by 503
Basic and Clinical Pharmacology
Holley, F. (1984) · Anesthesiology · doi:10.1097/00000542-198403000-00038 · Cited by 488
Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Baud, O., Foix-L'Helias, L., Kaminski, M., Audibert, F., Jarreau, P.-H., Papiernik, E., Huon, C., Lepercq, J., Dehan, M., & Lacaze-Masmonteil, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411604 · Cited by 414
Crowther, C. A., McKinlay, C. J., Middleton, P., & Harding, J. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003935.pub3 · Cited by 339
Self-citationRossi, S. (2012) · doi:10.1081/e-ecp-120006366 · Cited by 287
Report of the Australian and New Zealand Neonatal Network 2001
Donoghue, D. A. (2021) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/13 · Cited by 266
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
Doyle, L. W., & for the Victorian Infant Collaborative Study Group (2001) · Pediatrics · doi:10.1542/peds.108.1.134 · Cited by 237
Choice and dose of corticosteroid for antenatal treatments
Jobe, A. H., & Soll, R. F. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.044 · Cited by 213
Dalziel, S. R., Lim, V. K., Lambert, A., McCarthy, D., Parag, V., Rodgers, A., & Harding, J. E. (2005) · BMJ · doi:10.1136/bmj.38576.494363.e0 · Cited by 201
Crowther, C., & Harding, J. (2000) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003935 · Cited by 186
Self-citationMoïse, A. A., Wearden, M. E., Kozinetz, C. A., Gest, A. L., Welty, S. E., & Hansen, T. N. (1995) · Pediatrics · doi:10.1542/peds.95.6.845 · Cited by 171
Haram, K., Mortensen, J. H. S., & Wollen, A. (2003) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2003.00218.x · Cited by 152
Adverse Neonatal Outcomes Associated With Antenatal Dexamethasone Versus Antenatal Betamethasone
Lee, B. H., Stoll, B. J., McDonald, S. A., & Higgins, R. D. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1749 · Cited by 151
Use of Corticosteroids by Australian Obstetricians—A Survey of Clinical Practice
Quinlivan, J., Evans, S., Dunlop, S., Beazley, L., & Newnham, J. (1998) · Australian and New Zealand journal of obstetrics and gynaecology · doi:10.1111/j.1479-828x.1998.tb02947.x · Cited by 148
Functional abilities at age 4 years of children born before 29 weeks of gestation.
Johnson, A., Townshend, P., Yudkin, P. L., Bull, D., & Wilkinson, A. R. (1993) · BMJ · doi:10.1136/bmj.306.6894.1715 · Cited by 143
Mulder, E. J. H., Derks, J. B., & Visser, G. H. A. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb10969.x · Cited by 143
Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK
Brocklehurst, P., Gates, S., McKenzie‐McHarg, K., Alfirević, Ž., & Chamberlain, G. V. P. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08440.x · Cited by 138
Senat, M., Minoui, S., Multon, O., Fernandez, H., Frydman, R., & Ville, Y. (1998) · British Journal of Obstetrics and Gynaecology · doi:10.1111/j.1471-0528.1998.tb10206.x · Cited by 114
Antenatal corticosteroids revisited: repeat courses.
(2000) · PubMed · Cited by 112
Brownfoot, F., Crowther, C. A., & Middleton, P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006764.pub2 · Cited by 100
Self-citationLee, B. H., Stoll, B. J., McDonald, S. A., & Higgins, R. D. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1103 · Cited by 96
Subtil, D., Tiberghien, P., Devos, P., Therby, D., Leclerc, G., Vaast, P., & Puech, F. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.136 · Cited by 89
Magee, L. A., Dawes, G. S., Moulden, M., & Redman, C. W. G. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb10968.x · Cited by 89
Multiple courses of antenatal steroids: risks and benefits
Walfisch, A. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01368-0 · Cited by 80
Antenatal Betamethasone Compared With Dexamethasone (Betacode Trial): A Randomized Controlled Trial
Elimian, A., Garry, D. J., Figueroa, R., Spitzer, A. R., Wiencek, V., & Quirk, J. G. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000268281.36788.81 · Cited by 78
Rotmensch, S., Liberati, M., Vishne, T. H., Celentano, C., Ben‐Rafael, Z., & Bellati, U. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.780604.x · Cited by 73
Australian Medicines Handbook 2003
Howie, J. (2003) · Australian Prescriber · doi:10.18773/austprescr.2003.081 · Cited by 67
Egerman, R. S., Mercer, B. M., Doss, J. L., & Sibai, B. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70116-4 · Cited by 62
Betamethasone dosing interval: 12 or 24 hours apart? A randomized, noninferiority open trial.
Khandelwal, M., Chang, E., Hansen, C., Hunter, K., & Milcarek, B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.025 · Cited by 58
Henderson-Smart, D. J., Lumbiganon, P., Festin, M., Ho, J. J., Mohammad, H., McDonald, S. J., Green, S., Crowther, C. A., & the SEA-ORCHID Study Group (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-43 · Cited by 42
Self-citationThe effect of betamethasone versus dexamethasone on fetal biophysical parameters
Mushkat, Y., Ascher-Landsberg, J., Keidar, R., Carmon, E., Pauzner, D., & David, M. P. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00498-x · Cited by 42
Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles
Shanks, A. L., Gross, G. A., Shim, T. L., Allsworth, J. E., Sadovsky, Y., & Bildirici, İ. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.038 · Cited by 38
REPEATED COURSES OF ANTENATAL CORTICOSTEROIDS
Goldenberg, R. L., & Wright, L. L. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01153-4 · Cited by 37
Disposition of betamethasone in parturient women after intravenous administration
Petersen, M. C., Collier, C. B., Ashley, J. J., McBride, W. G., & Nation, R. L. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542524 · Cited by 37
Egerman, R., Pierce, W. F., Andersen, R., Umstot, E., Carr, T., & Sibai, B. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00446-2 · Cited by 36
Whitt, G. G., Buster, J. E., Killam, A. P., & Scragg, W. H. (1976) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(76)90172-1 · Cited by 33
Liu, J. (2006) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fml028 · Cited by 30
Shahraki, A. D., Janghorbani, M., & Khalatbari, S. (2012) · PubMed Central · Cited by 25
Glucocorticoid use in patients with preterm premature rupture of the fetal membranes.
Imseis, H. M., & Iams, J. (1996) · Seminars in Perinatology · doi:10.1016/s0146-0005(96)80011-5 · Cited by 19
Romejko-Wolniewicz, E., Oleszczuk, L., Zaręba-Szczudlik, J., & Czajkowski, K. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.733758 · Cited by 18
Lefèbvre, Y., Marier, R., Amyot, G., Bilodeau, R., Hotte, R., Raynault, P., Durocher, J.-G., & Lanthier, A. (1976) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(76)90781-x · Cited by 17
The absorption by the human fetus of intra-amniotically injected cortisol
Murphy, B. E. P. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90054-1 · Cited by 11
Egerman, R. S., Walker, R. A., Mercer, B., Doss, J. L., Sibai, B., & Andersen, R. A. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70138-3 · Cited by 10
Changing physician's practice on antenatal corticosteroids in preterm birth.
Saengwaree, P., & Liabsuetrakul, T. (2005) · PubMed · Cited by 9
16: Betamethasone dosing interval–12 or 24 hours apart?
Khandelwal, M., Chang, E., Hansen, C., Hunter, K. M., & Milcarek, B. I. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.10.042 · Cited by 6
“Betacode trial”antenatal betamethasone compared to dexamethasone: A randomized controlled trial
Elimian, A., Garry, D. J., Figueroa, R., Spitzer, A. R., Wiencek, V., Ogburn, P. L., & Ouirk, J. G. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.10.010 · Cited by 5
Shanks, A. L., Gross, G. A., Shim, T. L., Allsworth, J. E., Moga, C. N., Sadovsky, Y., & Bildirici, İ. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.09.191 · Cited by 5
Cited by
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Roberts, D., Brown, J., Medley, N., & Dalziel, S. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub3 · Cited by 2,806
Mol, B. W. J., Roberts, C. T., Thangaratinam, S., Magee, L. A., de Groot, C. J. M., & Hofmeyr, G. J. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00070-7 · Cited by 1,597
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
McGoldrick, E., Stewart, F., Parker, R., & Dalziel, S. R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004454.pub4 · Cited by 614
Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002237 · Cited by 561
Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring
Fox, R., Kitt, J., Leeson, P., Aye, C. Y. L., & Lewandowski, A. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101625 · Cited by 440
Metadata
- Authors
- Brownfoot, F. C., Gagliardi, D. I., Bain, E., Middleton, P., & Crowther, C. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-08-29
- Issue
- 8
- Pages
- CD006764-CD006764
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2105621974
- Cited by
- 343
- References
- 57
- FWCI
- 26.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.